AB
VOR icon

Amalgamated Bank’s Vor Biopharma VOR Stock Holding History

Amalgamated Bank’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-64
Closed -$3K – 3113
2024
Q1 		$3K Sell
64
-100
-61% -$4.39K ﹤0.01% 2853
2023
Q4 		$7K Sell
164
-19
-10% -$784 ﹤0.01% 2917
2023
Q3 		$8K Hold
183
– – ﹤0.01% 2938
2023
Q2 		$11K Buy
+183
New +$16.7K ﹤0.01% 2944
2022
Q2 		– Sell
-119
Closed -$14K – 3211
2022
Q1 		$14K Buy
+119
New +$20.3K ﹤0.01% 2903

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Bank's VOR Position: Q2 2024 in Review

Amalgamated Bank sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 64 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in VOR in Q1 2022 and held it in 5 quarters. The position peaked at $14K in Q1 2022. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • Amalgamated Bank reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 64 Vor Biopharma shares in Q2 2024, an estimated $3K.
  • Amalgamated Bank first reported a position in Vor Biopharma in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Vor Biopharma position peaked at $14K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.